ATE394108T1 - Mittel und verfahren zum schutz, zur behandlung und zur reparatur von bindegewebe - Google Patents

Mittel und verfahren zum schutz, zur behandlung und zur reparatur von bindegewebe

Info

Publication number
ATE394108T1
ATE394108T1 AT99906947T AT99906947T ATE394108T1 AT E394108 T1 ATE394108 T1 AT E394108T1 AT 99906947 T AT99906947 T AT 99906947T AT 99906947 T AT99906947 T AT 99906947T AT E394108 T1 ATE394108 T1 AT E394108T1
Authority
AT
Austria
Prior art keywords
protecting
treating
methods
connective tissue
repairing connective
Prior art date
Application number
AT99906947T
Other languages
English (en)
Inventor
Dvm Henderson
Rn Corson
Tarek Hammad
Medhat Soliman
Louis Lippiello
Original Assignee
Nutramax Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutramax Lab Inc filed Critical Nutramax Lab Inc
Application granted granted Critical
Publication of ATE394108T1 publication Critical patent/ATE394108T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44Oxidoreductases (1)
    • A61K38/446Superoxide dismutase (1.15)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Reinforced Plastic Materials (AREA)
  • Inorganic Insulating Materials (AREA)
AT99906947T 1998-02-13 1999-02-12 Mittel und verfahren zum schutz, zur behandlung und zur reparatur von bindegewebe ATE394108T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7459498P 1998-02-13 1998-02-13

Publications (1)

Publication Number Publication Date
ATE394108T1 true ATE394108T1 (de) 2008-05-15

Family

ID=22120420

Family Applications (2)

Application Number Title Priority Date Filing Date
AT99906947T ATE394108T1 (de) 1998-02-13 1999-02-12 Mittel und verfahren zum schutz, zur behandlung und zur reparatur von bindegewebe
AT08075016T ATE455548T1 (de) 1998-02-13 1999-02-12 Mittel und verfahren zum schutz, zur behandlung und reparatur von bindegewebe

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT08075016T ATE455548T1 (de) 1998-02-13 1999-02-12 Mittel und verfahren zum schutz, zur behandlung und reparatur von bindegewebe

Country Status (12)

Country Link
EP (2) EP1053000B1 (de)
JP (1) JP2002502881A (de)
AT (2) ATE394108T1 (de)
AU (1) AU764431B2 (de)
CA (1) CA2320202C (de)
CY (1) CY1108110T1 (de)
DE (2) DE69938036D1 (de)
DK (2) DK1917966T3 (de)
ES (2) ES2302373T3 (de)
HK (1) HK1120211A1 (de)
PT (2) PT1053000E (de)
WO (1) WO1999040926A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6656925B2 (en) * 1998-09-09 2003-12-02 Advanced Medical Instruments Composition and method of treating arthritis
DE20004010U1 (de) 2000-03-02 2000-06-21 Febena Pharma GmbH, 50825 Köln Diätische Zusammensetzung mit einem Gehalt an Glycosaminoglycanen
DE10054257A1 (de) * 2000-11-02 2002-05-16 Kief Horst Heilmittel zur Intraarticulären Injektion
FR2842738B1 (fr) * 2002-07-23 2006-02-10 Negma Lerads Utilisation d'une rheine pour la preparation d'un medicament pour le traitement de l'inflammation chronique, la prevention et le traitement du rejet des transplantations d'organes et de tissus
US20050090551A1 (en) * 2003-10-27 2005-04-28 Board Of Trustees Of Southern Illinois University Therapeutic use of methionine for the treatment or prevention of mucositis
WO2005051326A2 (en) * 2003-11-24 2005-06-09 Optimer Pharmaceuticals, Inc. Treatment of a condition in a mammal with administration of compounds and methods of use thereof
MX2007011931A (es) * 2007-09-26 2009-03-26 World Trade Imp Export Wtie Ag Composicion farmaceutica que comprende la combinacion de un agente antiartritico y un agente inhibidor de la interleucina-1, util para el control y tratamiento de la osteoartritis y enfermedades relacionadas.
US8455436B2 (en) 2010-12-28 2013-06-04 Depuy Mitek, Llc Compositions and methods for treating joints
US8398611B2 (en) 2010-12-28 2013-03-19 Depuy Mitek, Inc. Compositions and methods for treating joints
US11000533B2 (en) 2011-03-25 2021-05-11 Trackside Technologies Pty Ltd. Connective tissue monitoring, compositions for connective tissue treatment and methods for treating connective tissue
NZ616660A (en) * 2011-03-25 2016-05-27 Trackside Technologies Pty Ltd Connective tissue monitoring, compositions for connective tissue treatment and methods for treating connective tissue
US9682099B2 (en) 2015-01-20 2017-06-20 DePuy Synthes Products, Inc. Compositions and methods for treating joints
WO2021154774A1 (en) * 2020-01-29 2021-08-05 Lonza Consumer Health Inc. Joint health composition and use thereof in healthy mammals
WO2024018955A1 (ja) * 2022-07-19 2024-01-25 サントリーホールディングス株式会社 経口組成物、及び、エルゴチオネインに由来する苦味及びグルコサミン類化合物に由来する異味を抑制する方法
WO2024018956A1 (ja) * 2022-07-19 2024-01-25 サントリーホールディングス株式会社 経口組成物、及び、エルゴチオネイン又はその塩に由来する苦味及びコンドロイチン硫酸又はその塩に由来する臭みを抑制する方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB856493A (en) * 1957-10-04 1960-12-21 Pfizer & Co C Therapeutic compositions comprising tetracycline antibiotics
FR2193M (fr) * 1962-09-10 1963-12-09 Lipha Nouveau médicament pour le traitement des maladies infectieuses.
US4704383A (en) * 1983-12-29 1987-11-03 The Research Foundation Of State University Of New York Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same
US4925833A (en) * 1983-12-29 1990-05-15 The Research Foundation Of State University Of New York Use of tetracycline to enhance bone protein synthesis and/or treatment of osteoporosis
GB8507058D0 (en) * 1985-03-19 1985-04-24 Efamol Ltd Pharmaceutical & dietary compositions
JPS63203628A (ja) * 1987-02-19 1988-08-23 Taiyo Kagaku Co Ltd 動物の乳房炎治療剤
US5770209A (en) * 1991-08-30 1998-06-23 University Of South Florida Acceleration of wound healing using connective tissue growth factor
US5258371A (en) * 1992-05-29 1993-11-02 Kuraray Co., Ltd. Method to reduce connective tissue destruction
US5364845C1 (en) * 1993-03-31 2002-09-10 Nutramax Lab Inc Glusosamine chondroitin and manganese composition for the protection and repair of connective tissue
FR2707087B1 (fr) * 1993-06-28 1995-10-13 Bioxytech Nouveau procédé de préparation de l'ergothionéine.
GB9403857D0 (en) * 1994-03-01 1994-04-20 Scotia Holdings Plc Fatty acid derivatives
JPH09143492A (ja) * 1995-11-17 1997-06-03 Katsumasa Koike 酸化脂質の確認方法及び酸化脂質の生成方法
NL1003503C2 (nl) * 1996-07-04 1998-01-07 Negma Steba International Dev Farmaceutische samenstelling voor orale toediening.
IT1288257B1 (it) * 1996-11-29 1998-09-11 Paoli Ambrosi Gianfranco De Composizione per uso cosmetico,farmaceutico o dietetico a base di un aminozucchero e/o di un acido poliidrossilico

Also Published As

Publication number Publication date
DK1053000T3 (da) 2008-09-01
JP2002502881A (ja) 2002-01-29
CY1108110T1 (el) 2014-02-12
EP1053000A4 (de) 2003-01-29
PT1053000E (pt) 2008-07-11
HK1120211A1 (en) 2009-03-27
ES2302373T3 (es) 2008-07-01
ES2338946T3 (es) 2010-05-13
DE69938036D1 (de) 2008-03-13
ATE455548T1 (de) 2010-02-15
PT1917966E (pt) 2010-03-17
EP1917966A1 (de) 2008-05-07
AU2674099A (en) 1999-08-30
CA2320202A1 (en) 1999-08-19
DK1917966T3 (da) 2010-03-15
CA2320202C (en) 2010-09-14
DE69941966D1 (de) 2010-03-11
EP1917966B1 (de) 2010-01-20
EP1053000B1 (de) 2008-05-07
AU764431B2 (en) 2003-08-21
EP1053000A1 (de) 2000-11-22
WO1999040926A1 (en) 1999-08-19

Similar Documents

Publication Publication Date Title
HK1120211A1 (en) Agents and methods for protection, treatment and repair of connective tissue
ATE477270T1 (de) Verfahren und zusammensetzungen zur prävention und behandlung von anämie
DE69726289D1 (de) Verfahren und zusammensetzung zur behandlung von substraten bezüglich benetzbarkeit
ATE257385T1 (de) Zusammensetzungen und verfahren zur behandlung des erhöhten augenindruckes
ATE224138T1 (de) Zusammensetzungen und verfahren zur behandlung von pflanzen mit exogenen chemikalien
DE69429369D1 (de) Verfahren und mittel zur behandlung abnormaler zustände des epitheliums von körperöffnungen
ATE284210T1 (de) Verfahren und zusammensetzung zur behandlung von krebs
ATE455092T1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
ATE250576T1 (de) Substituierte pyrrolylverbindungen zur behandlung von entzündungen
DE69603089D1 (de) Zusammensetzung zur behandlung von mauerwerk
DE69231592D1 (de) Verfahren und zusammensetzungen zur behandlung von malaria und anderen erkrankungen
DE60013266D1 (de) Steroidnitrate zur behandlung von oxidativen schädigungen und endothelialer dysfunktion
ATA11989A (de) Mittel zur vorbeugung gegen und behandlung von parodontopathien
DE60009665D1 (de) Zusammensetzungen zur behandlung von entzündungsreaktionen
DE69905616D1 (de) Verfahren und zusammensetzung zur behandlung und vorbeugung von mycobacterium infektionen
DE69941821D1 (de) Fluorenthaltende zusammensetzung zur behandlung von oberflächen
ATE190843T1 (de) Zubereitungen zur behandlung von impotenz, die ein alpha-1 inhibitor und ein alpha-2 inhibitor enthalten
DE69900339D1 (de) Mittel und Verfahren zur Behandlung von Kunstfasern
DE69808475D1 (de) Aminosäurederivate zur behandlung von schlaganfall
DE69535366D1 (de) Zusammensetzung zur behandlung und vorbeugung von hiv-1 infektionen, welche mindestens zwei verschiedene hiv-1 reverse transcriptase inhibitoren enthalt
ATE292962T1 (de) Verwendung einer zusammensetzung zur herstellung eines arzneimittels zur vorbeugung und behandlung von parodontitis
DE69928501D1 (de) Mittel zur vorbeugung/behandlung von osteoporose
DE60028831D1 (de) Zusammensetzungen und verfahren zur behandlung von epilepsie
DE69000960D1 (de) Zusammensetzung zur behandlung von pigmentierung.
DE60000658D1 (de) Zusammensetzung zur behandlung von psoriasis

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1053000

Country of ref document: EP